Qinghai Spring Medicinal Resources Technology Co., Ltd. Stock price

Equities

600381

CNE0000017W0

Pharmaceuticals

End-of-day quote Shanghai S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
5.03 CNY +0.80% Intraday chart for Qinghai Spring Medicinal Resources Technology Co., Ltd. -12.67% -34.93%
Sales 2021 128M 17.69M Sales 2022 160M 22.18M Capitalization 7.23B 1B
Net income 2021 -249M -34.48M Net income 2022 -288M -39.89M EV / Sales 2021 37.2 x
Net cash position 2021 198M 27.49M Net cash position 2022 164M 22.78M EV / Sales 2022 44.1 x
P/E ratio 2021
-20.1 x
P/E ratio 2022
-25.1 x
Employees 175
Yield 2021 *
-
Yield 2022
-
Free-Float 55.91%
More Fundamentals * Assessed data
Dynamic Chart
Qinghai Spring Medicinal Resources Probed Over Misleading Ad for Rice Wine MT
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Qinghai Spring Medicinal Resources Technology Co., Ltd.(XSSC:600381) added to S&P Global BMI Index CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Beijing Life Capital Management Co., Ltd. completed the acquisition of a 5% stake in Qinghai Spring Medicinal Resources Technology Co., Ltd. from Tibet Rongen Technology Co., Ltd. CI
Beijing Life Capital Management Co., Ltd. signed the share transfer agreement to acquire a 5% stake in Qinghai Spring Medicinal Resources Technology Co., Ltd. from Tibet Rongen Technology Co., Ltd. for approximately CNY 200 million. CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. Announces Earnings Results for the First Quarter Ended March 31, 2021 CI
More news
1 day+0.80%
1 week-12.67%
Current month-14.89%
1 month-11.75%
3 months-34.76%
6 months-36.89%
Current year-34.93%
More quotes
1 week
4.89
Extreme 4.89
5.47
1 month
4.89
Extreme 4.89
6.95
Current year
4.55
Extreme 4.55
8.28
1 year
4.55
Extreme 4.55
10.09
3 years
4.55
Extreme 4.55
20.67
5 years
4.22
Extreme 4.22
20.67
10 years
4.22
Extreme 4.22
50.09
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 15-10-29
Director of Finance/CFO 55 18-05-17
Director/Board Member 71 15-05-14
Members of the board TitleAgeSince
Director/Board Member 86 20-06-03
Director/Board Member 54 -
Chief Executive Officer 55 15-10-29
More insiders
Date Price Change Volume
24-03-28 5.03 +0.80% 17,081,530
24-03-27 4.99 -5.67% 21,688,080
24-03-26 5.29 +2.12% 22,219,560
24-03-25 5.18 -5.82% 28,941,580
24-03-22 5.5 -4.51% 40,202,440

End-of-day quote Shanghai S.E., March 27, 2024

More quotes
QINGHAI SPRING MEDICINAL RESOURCES TECHNOLOGY CO.,LTD is a China-based company that principally engaged in the integrated development, utilization, production, sales and consulting services of the natural advantageous resources on the Qinghai-Tibet plateau, as well as the development and utilization of other biological resources. The Company's main products are the cordyceps sinensis series products under Verygrass brand, which includes cordyceps sinensis pure powder tablet, processed cordyceps sinensis and raw cordyceps sinensis. The Company's subsidiary is Qinghai Spring Pharmaceutical Resource Utilization Co Ltd.
More about the company

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Qinghai Spring Medicinal Resources Technology Co., Ltd. - Shanghai S.E.